Allergan.com - Allergan is now part of AbbVie | AbbVie

Provided by Alexa ranking, allergan.com has ranked N/A in N/A and 6,406,270 on the world. allergan.com reaches roughly 482 users per day and delivers about 14,451 users each month. The domain allergan.com uses a Commercial suffix and it's server(s) are located in N/A with the IP number 159.180.132.176 and it is a .com domain.

WEBAllergan is now part of AbbVie. We discover and develop innovative medicines for tomorrow, while helping people live better lives today. Our products. We offer over 30+ brands treating 60+ conditions from oncology and immunology to aesthetics and eye care.

List of domain same IP 159.180.132.176

Search Results related to allergan.com on Search Engine

Allergan is now part of AbbVie | AbbVie
abbvie.com

https://www.abbvie.com/allergan.html

WEBAllergan is now part of AbbVie. We discover and develop innovative medicines for tomorrow, while helping people live better lives today. Our products. We offer over 30+ brands treating 60+ conditions from oncology and immunology to aesthetics and eye care.

DA: 51 PA: 2 MOZ Rank: 14

Allergan Aesthetics | An AbbVie Company
allerganaesthetics.com

https://www.allerganaesthetics.com/

WEBAllergan Aesthetics develops, manufactures, and markets a portfolio of leading brands and products including facial injectables, body contouring, plastics, skin care, and more.

DA: 44 PA: 71 MOZ Rank: 92

Allergan - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Allergan

WEBAllergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. [1] [2] [3] The company is the maker of Botox.

DA: 30 PA: 60 MOZ Rank: 76

Allergan is now part of AbbVie | AbbVie
abbvie.ca

https://www.abbvie.ca/en/abbvie-allergan-overview.html

WEBAllergan is now part of AbbVie. Together, we are dedicating more to R&D to drive tomorrow’s breakthroughs, while helping people live better lives today. With the Allergan acquisition, we are bringing together over 30 brands and leadership positions to expand and diversify our product portfolio.

DA: 46 PA: 53 MOZ Rank: 68

Three factors that drove the transformational integration of AbbVie
abbvie.com

https://www.abbvie.com/who-we-are/our-stories/three-factors-that-drove-transformational-integration-abbvie-allergan.html

WEBNov 30, 2022 · That day, AbbVie officially closed its $63-billion acquisition of Allergan to create a larger, stronger and more diversified global biopharmaceutical company. It was an acquisition that allowed us to grow in numbers and bolster our ability to improve people’s lives worldwide.

DA: 32 PA: 44 MOZ Rank: 50

Allergan, Inc. - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Allergan,_Inc.

WEBAllergan, Inc. was an American global pharmaceutical company focused on eye care, neurosciences, medical dermatology, medical aesthetics, breast enhancement, obesity intervention and urologics. Allergan, Inc. was formed in 1948, incorporated in 1950 and became a public company in 1970.

DA: 36 PA: 90 MOZ Rank: 92

AbbVie Completes Transformative Acquisition of Allergan
abbvie.com

https://news.abbvie.com/2020-05-08-AbbVie-Completes-Transformative-Acquisition-of-Allergan

WEBNORTH CHICAGO, Ill., May 8, 2020 / PRNewswire / -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced today that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities required by the transaction agreement and approval by the Irish High Court.

DA: 12 PA: 39 MOZ Rank: 59

Allergan Reaches Tentative $2.37 Billion Deal to Settle Opioid Suits
nytimes.com

https://www.nytimes.com/2022/07/29/health/allergan-opioids-settlement.html

WEBJul 29, 2022 · A bipartisan group of state attorneys general announced Friday morning that it had struck an agreement in principle with the pharmaceutical company Allergan for $2.37 billion to resolve more than...

DA: 75 PA: 98 MOZ Rank: 99

AbbVie to Acquire Allergan in Transformative Move for Both …
prnewswire.com

https://www.prnewswire.com/news-releases/abbvie-to-acquire-allergan-in-transformative-move-for-both-companies-300874219.html

WEBJun 25, 2019 · /PRNewswire/ -- AbbVie Inc. (NYSE: ABBV) and Allergan plc (NYSE: AGN) announced that the companies have entered into a definitive transaction agreement under...

DA: 36 PA: 68 MOZ Rank: 66

Allergan | LinkedIn
linkedin.com

https://www.linkedin.com/company/allergan

WEBProviding guidance to companies struggling to find, build, launch or grow their next multi-million dollar data and AI (NLP) products. Allergan | 688,833 followers on LinkedIn. Allergan is now...

DA: 68 PA: 13 MOZ Rank: 42

Alexa Rank

GLOBAL RANK

6,406,270

Alexa Reach

0.0000212640

Page length

N/A

Alexa Rank Country N/A

N/A

Daily Unique Visitors

482

Monthly Unique Visitors

14,451

Vistor via Country

Country lang

Country code

Total visitor

Country

Country code

Total visitor

United States

3,091

Indonesia

2,418

Taiwan

786

United Kingdom

698

Brazil

632

Nigeria

552

Egypt

464

Hong Kong

438

Canada

438

Australia

382

Philippines

273

India

266

Malaysia

262

Spain

217

Germany

211

Mexico

202

France

191

Italy

176

Turkey

162

Iraq

147

Thailand

145

Netherlands

139

Israel

137

Cambodia

114

Algeria

Ireland

Romania

Jordan

Poland

Ghana

Argentina

South Africa

Belgium

Czechia

Ukraine

Japan

Morocco

South Korea

Lebanon

Saudi Arabia

Austria

Hungary

Sweden

Singapore

Pakistan

Bangladesh

Denmark

Greece

Alexa Traffic Graph

Alexa daily traffic trend graph

Alexa daily pageviews (percent) graph

Alexa Statistics Graph for www.nahklick.de

Alexa daily pageviews per user graph

Alexa time on site (in minutes) graph

Alexa bounce rate (percent) graph

Alexa search visits graph

SEOquake Zone

Title			Tips
Description			Tips
Keywords			Tips
Viewport			Tips
Icon
UTF-8

Mini site formation by Alexa Rank

MOZ Rank

DNS Record

Host	Type	Class	TTL	Extra
allergan.com	A	IN	3600	Ip: 159.180.132.176
allergan.com	SOA	IN	21600	Mname: ns11.constellix.com Rname: dns.constellix.com Serial: 2015010179 Refresh: 43200 Retry: 3600 Expire: 1209600 Minimum-ttl: 180
allergan.com	NS	IN	21600	Target: ns21.constellix.com
allergan.com	NS	IN	21600	Target: ns31.constellix.com
allergan.com	NS	IN	21600	Target: ns41.constellix.net
allergan.com	NS	IN	21600	Target: ns51.constellix.net
allergan.com	NS	IN	21600	Target: ns61.constellix.net
allergan.com	NS	IN	21600	Target: ns11.constellix.com
allergan.com	MX	IN	3600	Pri: 5 Target: mx1.hc3464-92.iphmx.com
allergan.com	MX	IN	3600	Pri: 5 Target: mx2.hc3464-92.iphmx.com
allergan.com	TXT	IN	3600	Txt: ZOOM_verify_xgRQYliG5YwQyuOg8zQakW Entries_0: ZOOM_verify_xgRQYliG5YwQyuOg8zQakW
allergan.com	TXT	IN	3600	Txt: v=spf1 exists:%{i}._i.%{d}._d.espf.dmp.cisco.com include:%{d}.ff.spf-protect.dmp.cisco.com ~all Entries_0: v=spf1 exists:%{i}._i.%{d}._d.espf.dmp.cisco.com include:%{d}.ff.spf-protect.dmp.cisco.com ~all
allergan.com	TXT	IN	3600	Txt: z7n3hwcvk55w1v7ydvhqbgvm1crnmqd1 Entries_0: z7n3hwcvk55w1v7ydvhqbgvm1crnmqd1
allergan.com	TXT	IN	3600	Txt: docusign=29f2a4e2-b572-4bb2-a926-9ffc292282ad Entries_0: docusign=29f2a4e2-b572-4bb2-a926-9ffc292282ad
allergan.com	TXT	IN	3600	Txt: OeWnuCyBpbNNfA7vJlr3Zw7vq12BUQ9BFGoAgXAlwjuxPL94kTyG26y9ikFP4EnUexat8TvGJJyKhQB4mBWRXw== Entries_0: OeWnuCyBpbNNfA7vJlr3Zw7vq12BUQ9BFGoAgXAlwjuxPL94kTyG26y9ikFP4EnUexat8TvGJJyKhQB4mBWRXw==
allergan.com	TXT	IN	3600	Txt: MS=ms90627508 Entries_0: MS=ms90627508
allergan.com	TXT	IN	3600	Txt: docusign=8f3c218d-62d5-4640-a416-9f4d75a3614a Entries_0: docusign=8f3c218d-62d5-4640-a416-9f4d75a3614a
allergan.com	TXT	IN	3600	Txt: atlassian-domain-verification=hvPNxVl6SbKw85hBBqJKhfcfakEyaUowNW5hiUpD3btnQakNFy8UaOiSlwLcixwN Entries_0: atlassian-domain-verification=hvPNxVl6SbKw85hBBqJKhfcfakEyaUowNW5hiUpD3btnQakNFy8UaOiSlwLcixwN
allergan.com	TXT	IN	3600	Txt: have-i-been-pwned-verification=dweb_dnq9fbbtrzcadpdlyf635enm Entries_0: have-i-been-pwned-verification=dweb_dnq9fbbtrzcadpdlyf635enm
allergan.com	TXT	IN	3600	Txt: miro-verification=bbe6162f677d9bda8ebacef01a21451f04f35f73 Entries_0: miro-verification=bbe6162f677d9bda8ebacef01a21451f04f35f73
allergan.com	TXT	IN	3600	Txt: loom-site-verification=d245e75e7c934bc8a6710897717bdbd1 Entries_0: loom-site-verification=d245e75e7c934bc8a6710897717bdbd1

Hosting and Whois Zone

IP	159.180.132.176
Domain infomation	Domain Name: ALLERGAN.COM Registry Domain ID: 2620727_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2023-06-11T09:34:21Z Creation Date: 1994-07-14T04:00:00Z Registry Expiry Date: 2024-07-13T04:00:00Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: [email protected] Registrar Abuse Contact Phone: +1.2086851750 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited Name Server: NS11.CONSTELLIX.COM Name Server: NS21.CONSTELLIX.COM Name Server: NS31.CONSTELLIX.COM Name Server: NS41.CONSTELLIX.NET Name Server: NS51.CONSTELLIX.NET Name Server: NS61.CONSTELLIX.NET DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/ >>> Last update of whois database: 2024-04-24T00:40:39Z <<< For more information on Whois status codes, please visit https://icann.org/epp NOTICE: The expiration date displayed in this record is the date the registrar's sponsorship of the domain name registration in the registry is currently set to expire. This date does not necessarily reflect the expiration date of the domain name registrant's agreement with the sponsoring registrar. Users may consult the sponsoring registrar's Whois database to view the registrar's reported date of expiration for this registration. TERMS OF USE: You are not authorized to access or query our Whois database through the use of electronic processes that are high-volume and automated except as reasonably necessary to register domain names or modify existing registrations; the Data in VeriSign Global Registry Services' ("VeriSign") Whois database is provided by VeriSign for information purposes only, and to assist persons in obtaining information about or related to a domain name registration record. VeriSign does not guarantee its accuracy. By submitting a Whois query, you agree to abide by the following terms of use: You agree that you may use this Data only for lawful purposes and that under no circumstances will you use this Data to: (1) allow, enable, or otherwise support the transmission of mass unsolicited, commercial advertising or solicitations via e-mail, telephone, or facsimile; or (2) enable high volume, automated, electronic processes that apply to VeriSign (or its computer systems). The compilation, repackaging, dissemination or other use of this Data is expressly prohibited without the prior written consent of VeriSign. You agree not to use electronic processes that are automated and high-volume to access or query the Whois database except as reasonably necessary to register domain names or modify existing registrations. VeriSign reserves the right to restrict your access to the Whois database in its sole discretion to ensure operational stability. VeriSign may restrict or terminate your access to the Whois database for failure to abide by these terms of use. VeriSign reserves the right to modify these terms at any time. The Registry database contains ONLY .COM, .NET, .EDU domains and Registrars.